+44 1400530055Review Article - Journal of RNA and Genomics (2024) Volume 20, Issue 3
Genetic, demographic and virology study on active and mortality cases of COVID-19 across different countries of the world as at 12th October 17, 2022.
Introduction/aim: Since the first case of infection with a new Coronavirus was detected in China in December 2019, SARS-CoV-2 has killed more than 5 million people and infected hundreds of millions of others. It has since spread to almost every country. This project’s goal is to conduct a study on COVID-19 death cases and current cases around the world as of October 12, 2022.
Materials and methods: The United Nations geoscheme provided data for 132 nations and regions around the globe. After compiling the findings, they were compared to those discovered for the USA.
Results: The majority of the American continent has close active case and death values to those of the USA when considering that country as a comparism point. The mortality value in the majority of American nations is higher than the active case value. Some European nations have incidence values that are significantly greater than those of the USA. Additionally, the majority of European nations have a greater active case value than a death value. African and Asian nations are less valuable. Africa’s worth is the lowest of the two.
Conclusion: Genetic variation may have played a role in infectability and mortality of COVID-19 virus. Further study need to be done to determine the significance of various contributing factor that may be a lead to development of more robust vaccine now and in the future.
Author(s): Joseph Opeyemi Tosin*, Joseph Oyepata Simeon, Makinde Adeola Victoria, Sabastine Aliyu Zubairu